enfortumab vedotin,pembrolizumab
merck,astellas,seagen
[' vedo', 'pembro', 'enfortumab', 'ev-103', 'urothelial', 'rs onco']
#esmo22 video: here s our interview with about the latest data on first-line enfortumab vedotin alone or with pembrolizumab from the ev-103 trial in advanced urothelial cancer 
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.